[1] JOSEPH J, NAQVI S Y, GIRI J, et al. Aortic stenosis: pathophysiology, diagnosis, and therapy[J]. Am J Med, 2017, 130(3):253-263.
[2] GRIBIER A, ELTCHANINOFF H, BASH A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description[J]. Circulation, 2002, 106(24):3006-3008.
[3] FAROUX L, GUIMARAES L, WINTZER-WEHEKIND J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2019, 74(3):362-372.
[4] RIBEIRO H B, WEBB J G, MAKKAR R R, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry[J]. J Am Coll Cardiol, 2013, 62(17):1552-1562.
[5] HOLMES D J, MACK M J, KAUL S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement[J]. J Am Coll Cardiol, 2012, 59(13):1200-1254.
[6] BUELLESFELD L, STORTECKY S, KALESAN B, et al. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2013, 6(1):72-83.
[7] RIBEIRO H B, RODES-CABAU J, BLANKE P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry[J]. Eur Heart J, 2018, 39(8):687-695.
[8] YAMAMOTO M, SHIMURA T, KANO S, et al. Impact of preparatory coronary protection in patients at high anatomical risk of acute coronary obstruction during transcatheter aortic valve implantation[J]. Int J Cardiol, 2016, 217:58-63.
[9] PALMERINI T, CHAKRAVARTY T, SAIA F, et al. Coronary protection to prevent coronary obstruction during TAVR: A Multicenter International Registry[J]. JACC Cardiovasc Interv, 2020, 13(6):739-747.
[10] BLUMENSTEIN J, KIM W K, LIEBETRAU C, et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI[J]. Clin Res Cardiol, 2015, 104(8):632-639.
[11] PENKALLA A, PASIC M, DREWS T, et al. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approachdagger[J]. Eur J Cardiothorac Surg, 2015, 47(6):1083-1089.
[12] CHAKRAVARTY T, SHARMA R, ABRAMOWITZ Y, et al. Outcomes in patients with transcatheter aortic valve replacement and left main stenting: The TAVR-LM Registry[J]. J Am Coll Cardiol, 2016, 67(8):951-960.
[13] VOUDRIS K V, PETROPULOS P, KARYOFILLIS P, et al. Timing and outcomes of PCI in the TAVR era[J]. Curr Treat Options Cardiovasc Med, 2018, 20(3):22. |
